[HTML][HTML] Theoretical models of nonlinear effects in two-component cooperative supramolecular copolymerizations

…, HMM Ten Eikelder, PAJ Hilbers, TF De Greef… - Nature …, 2011 - nature.com
… Filot, IAW, Palmans, ARA, Hilbers, PAJ, van Santen, RA, Pidko, EA & de Greef, TFA …
Markvoort, Huub MM ten Eikelder, Peter AJ Hilbers & Tom FA de Greef … Tom FA de Greef

Symmetry breaking in the self-assembly of partially fluorinated benzene-1, 3, 5-tricarboxamides.

…, PA Korevaar, MA Gillissen, TF de Greef… - … (International ed. in …, 2012 - europepmc.org
The interplay of two subsequent aggregation processes results in a symmetry-breaking
phenomenon in an achiral self-assembling system. Partially fluorinated benzene-1, 3, 5-…

Effects of model definitions and parameter values in finite element modeling of human middle ear mechanics

D De Greef, F Pires, JJJ Dirckx - Hearing research, 2017 - Elsevier
… It should be noted that the frequency spacing used in this paper is rather coarse compared
to the fine structure of the TF in the high frequency range (>4 kHz) (see Fig. 2B), which limits …

Greening of etiolated bean leaves in far red light

J De Greef, WL Butler, TF Roth - Plant physiology, 1971 - academic.oup.com
Eight-day-old dark-grown bean leaves were greened by prolonged irradiation with far red
light. Growth, chlorophyll content, oxygen-evolving capacity, photophosphorylation capacity, …

Control of Senescence in Marchantia by Phytochrome

J De Greef, WL Butler, TF Roth, H Fredericq - Plant physiology, 1971 - academic.oup.com
DE GREEF. 1966. Influence, reversible par la lumiere rouge-clair, de courts 6clairements
rouge-fonce A la fin de la … Aim JA DE GREEF. Photomorphogenic and chlorophyll studies in the …

[HTML][HTML] Evaluation of dosing strategy for pembrolizumab for oncology indications

…, M Ahamadi, CH Li, R de Greef, D de Alwis… - … for immunotherapy of …, 2017 - Springer
Background Traditionally, most monoclonal antibodies (mAbs) have been dosed based on
body weight because of perceived contribution of body size in pharmacokinetic variability. …

[HTML][HTML] Immunogenicity of pembrolizumab in patients with advanced tumors

MJH van Vugt, JA Stone, RH De Greef… - … for ImmunoTherapy of …, 2019 - Springer
… MJHvV, ESS, LL, and TF drafted the manuscript with contributions from all authors. JAS,
HJMMdG, LL, DCT, AC, ML, M. Li, SHR, DDA, KM, LJ, and TF critically reviewed or revised the …

Model‐based characterization of the pharmacokinetics of pembrolizumab: a humanized anti–PD‐1 monoclonal antibody in advanced solid tumors

…, CH Li, DP De Alwis, R De Greef… - CPT …, 2017 - Wiley Online Library
Pembrolizumab, a potent antibody against programmed death 1 (PD‐1) receptor, has shown
robust antitumor activity and manageable safety in patients with advanced solid tumors. Its …

[PDF][PDF] Mutations in ZBTB24 are associated with immunodeficiency, centromeric instability, and facial anomalies syndrome type 2

JC De Greef, J Wang, J Balog, JT Den Dunnen… - The American Journal of …, 2011 - cell.com
… DNMT3B is one of the three main mammalian DNA methyltransferases that play an important
but not exclusive role in de novo DNA methylation.In ICF1 patients, the enzymatic activity of …

[HTML][HTML] Engineering cytokine therapeutics

…, TJ Beldman, JB Spangler, TFA de Greef… - Nature Reviews …, 2023 - nature.com
Cytokines have pivotal roles in immunity, making them attractive as therapeutics for a variety
of immune-related disorders. However, the widespread clinical use of cytokines has been …